Ciprofloxacin versus Aminoglycoside–Ciprofloxacin for Bubonic Plague
Article Details
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
Authors (18)
Rindra Vatosoa Randremanana
Institut Pasteur de Madagascar, Antananarivo
Mihaja Raberahona
Centre Hospitalier Universitaire (CHU) Joseph Raseta Befelatanana, Antananarivo, Madagascar
Josephine Bourner
International Severe Acute Respiratory and Emerging Infection Consortium, Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
Minoarisoa Rajerison
Plague Unit, Institut Pasteur de Madagascar
Tansy Edwards
International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London
Ravaka Randriamparany
Institut Pasteur de Madagascar, Antananarivo
Tsinjo Fehizoro Razafindratsinana
Institut Pasteur de Madagascar, Antananarivo
Lisy Hanitra Razananaivo
Institut Pasteur de Madagascar, Antananarivo
Gabriella Zadonirina
Institut Pasteur de Madagascar, Antananarivo
Théodora Mayouya-Gamana
Institut Pasteur de Madagascar, Antananarivo
Alex Paddy Abdel Salam
International Severe Acute Respiratory and Emerging Infection Consortium, Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
Reziky Tiandraza Mangahasimbola
Institut Pasteur de Madagascar, Antananarivo
Voahangy Andrianaivoarimanana
Institut Pasteur de Madagascar, Antananarivo
Elise Pesonel
Centre d’Infectiologie Charles Mérieux, Université d’Antananarivo, Antananarivo, Madagascar
Rivonirina Andry Rakotoarivelo
Équipe de Recherche Clinique en Maladies Infectieuses, Antananarivo, Madagascar
Mamy Jean de Dieu Randria
Centre Hospitalier Universitaire (CHU) Joseph Raseta Befelatanana, Antananarivo, Madagascar
Peter Horby
International Severe Acute Respiratory and Emerging Infection Consortium, Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
Piero Olliaro
International Severe Acute Respiratory and Emerging Infection Consortium, Pandemic Sciences Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom